miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1S expression
Article in Open Biology (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Rare disease + lots of sequencing = mechanism?
Article in Blood (April 2021)
From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants
Article in Human Mutation (September 2019)